Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pasquale Pagliano and Amelia Filippelli.
Pasquale Pagliano
Connection Strength
3.195
Amelia Filippelli
  1. An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19). Expert Opin Drug Discov. 2022 01; 17(1):9-18.
    View in: PubMed
    Score: 0.964
  2. Experimental Pharmacotherapy for COVID-19: The Latest Advances. J Exp Pharmacol. 2021; 13:1-13.
    View in: PubMed
    Score: 0.923
  3. Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019? Clin Infect Dis. 2020 07 28; 71(15):887-888.
    View in: PubMed
    Score: 0.895
  4. Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis. J Pers Med. 2021 Jul 01; 11(7).
    View in: PubMed
    Score: 0.238
  5. BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19. J Gerontol A Biol Sci Med Sci. 2021 09 13; 76(10):1775-1783.
    View in: PubMed
    Score: 0.060
  6. PD-L1 Dysregulation in COVID-19 Patients. Front Immunol. 2021; 12:695242.
    View in: PubMed
    Score: 0.059
  7. Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Front Pharmacol. 2020; 11:857.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.